RICE HALL JAMES & ASSOCIATES, LLC - ADAMAS PHARMACEUTICALS INC ownership

ADAMAS PHARMACEUTICALS INC's ticker is ADMS and the CUSIP is 00548A106. A total of 128 filers reported holding ADAMAS PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 0.40 and the average weighting 0.2%.

Quarter-by-quarter ownership
RICE HALL JAMES & ASSOCIATES, LLC ownership history of ADAMAS PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2019$586,000
+199.0%
82,413
+259.4%
0.02%
+171.4%
Q4 2018$196,000
-42.9%
22,928
+33.9%
0.01%
-41.7%
Q3 2018$343,00017,1180.01%
Other shareholders
ADAMAS PHARMACEUTICALS INC shareholders Q3 2018
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 808,431$3,501,0002.68%
AIGH Capital Management LLC 875,851$3,793,0001.54%
Healthcare Value Capital, LLC 100,000$433,0001.46%
SILVERARC CAPITAL MANAGEMENT, LLC 440,955$1,909,0001.11%
Opaleye Management Inc. 1,487,800$6,442,0000.84%
Worth Venture Partners, LLC 225,106$975,0000.77%
ARMISTICE CAPITAL, LLC 2,742,000$11,873,0000.40%
DELTEC ASSET MANAGEMENT LLC 245,399$1,063,0000.16%
ESSEX INVESTMENT MANAGEMENT CO LLC 278,011$1,204,0000.15%
Mosaic Family Wealth, LLC 91,807$398,0000.13%
View complete list of ADAMAS PHARMACEUTICALS INC shareholders